DRUG Watch

Author/Creator ORCID

Date

2017-06

Department

Sandra R. Berman School of Nursing and Health Professions

Program

Nursing

Citation of Original Publication

Aschenbrenner, D. S. (2017). Drug watch. AJN American Journal Of Nursing, 117(6), 22-23.

Rights

Subjects

Abstract

The article reports on drugs that received approval from the U.S. Food and Drug Administration. It notes on the approval given to deflazacort (Emflaza) as treatment for Duchenne muscular dystrophy, the most common type of muscular dystrophy characterized by progressive muscle deterioration and weakness starting in childhood. It cites the approval given to brodalumab (Siliq) as treatment for moderate-to-severe plaque psoriasis, an autoimmune disease that causes patches of red and flaky skin.